sulfonylurea vs glp 1 Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records GLP-1 Receptor Agonists and Research

Over 72 weeks patients without diabetes lost 15%, 19%, and 21% of body weight on the 5, 10, and 15 mg weekly SQ injections, respectively

- Mechanism Difference: The trial suggests that metformins benefits in T1D may occur through mechanisms independent of insulin resistance, such as increasing levels of GDF15, a hormone linked to appetite and weight regulation

Louis Aronne, MD, FACP, a leading authority in weight management and GLP-1 therapy, this line is designed to support those using GLP-1 medications, or otherwise cutting calories to lose weight, by addressing the nutrient deficiencies that commonly arise during weight loss

[3] [4] The appetite suppression is the primary mechanism behind its effectiveness for weight loss